Home

bloquer Objecteur pois Running colorées sanofi Quoi tiret législation

Sanofi launches new corporate brand and logo, and that goes for Genzyme and  Sanofi Pasteur, too | Fierce Pharma
Sanofi launches new corporate brand and logo, and that goes for Genzyme and Sanofi Pasteur, too | Fierce Pharma

France's Sanofi to buy U.S. biopharma firm Kadmon in $1.9 bln deal | Reuters
France's Sanofi to buy U.S. biopharma firm Kadmon in $1.9 bln deal | Reuters

Sanofi | Paris
Sanofi | Paris

A history of Sanofi
A history of Sanofi

Contact Us - Sanofi U.S.
Contact Us - Sanofi U.S.

Sanofi, AZ's RSV contender nears first global approval
Sanofi, AZ's RSV contender nears first global approval

GI toxicity hits midstage Sanofi GLP-1 drug as patients drop out | Fierce  Biotech
GI toxicity hits midstage Sanofi GLP-1 drug as patients drop out | Fierce Biotech

Is Sanofi A Buy, Despite Recent Stumbles? | Entrepreneur
Is Sanofi A Buy, Despite Recent Stumbles? | Entrepreneur

Technip Energies | Projects | Sanofi Algeria pharmaceutical production  plant | Largest pharmaceutical production plant in Africa
Technip Energies | Projects | Sanofi Algeria pharmaceutical production plant | Largest pharmaceutical production plant in Africa

Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data | Reuters
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data | Reuters

Sanofi and Habitat for Humanity join forces to help Monroe County man
Sanofi and Habitat for Humanity join forces to help Monroe County man

Regeneron and Sanofi Look for Billions From COPD Drug - WSJ
Regeneron and Sanofi Look for Billions From COPD Drug - WSJ

Aventis Accepts Sanofi Bid – DW – 04/26/2004
Aventis Accepts Sanofi Bid – DW – 04/26/2004

Diabetes Drug Giant Sanofi Cuts Insulin Prices by Up to 78% - WSJ
Diabetes Drug Giant Sanofi Cuts Insulin Prices by Up to 78% - WSJ

Home - Sanofi U.S.
Home - Sanofi U.S.

Former Sanofi CEO Brandicourt takes board seat at RNAi therapy maker  Alnylam | Fierce Pharma
Former Sanofi CEO Brandicourt takes board seat at RNAi therapy maker Alnylam | Fierce Pharma

Sanofi begins moving into big Boston HQ
Sanofi begins moving into big Boston HQ

Inside Sanofi's General Medicines Unit: Embracing A New Commercial Model ::  In Vivo
Inside Sanofi's General Medicines Unit: Embracing A New Commercial Model :: In Vivo

Sanofi launches global health brand with non-profit treatments | Reuters
Sanofi launches global health brand with non-profit treatments | Reuters